which glp-1 is best works best? New meta-study puts them head-to-head This advanced GLP Which GLP-1 Is Best for
Description
Semaglutide is less effective at reducing body weight in T2D patients compared to patients without (5% weight loss, SUSTAIN-6 and 15% weight loss, STEP, respectively)

Ongoing studies aim to further elucidate the perioperative safety profile of these therapies
Targeted GLP-1 companion supplementation, guided by laboratory values and clinical context, may help support nutritional adequacy during GLP-1 therapy

At present, tirzepatide is the leading GLP-1/GIP dual agonist and has been approved for marketing in many countries, including the US, Europe and Japan, for the treatment of T2D
The catch: its a temporary pilot program with an uncertain outlook after 2027
If your nausea continues or becomes severe, talk your doctor or pharmacist
